The annual meeting of the American College of Obstetricians and Gynecologists was held from May 2 to 6 in San Francisco and attracted more than 3,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in obstetrics and gynecology. The conference highlighted recent advances in the prevention, detection, and treatment of conditions impacting women, with presentations focusing on the advancement of health care services for women worldwide.
In one study, Janice Mitchell, M.D., of the Baylor University Medical Center in Dallas, and colleagues found that uterine cooling during cesarean delivery reduced blood loss by 29 percent and the incidence of postpartum hemorrhage by 57 percent.
“Uterine cooling is effective for decreasing blood loss during cesarean and may be a novel therapy for uterine atony,” Mitchell said. “A second study is currently undergoing Institutional Review Board approval at the Baylor University Medical Center that will evaluate the same method in patients who require cesarean delivery after a trial of labor.”
In another study, Katherine Scolari Childress, M.D., of the Saint Louis University School of Medicine, and colleagues found that treatment with intravenous metoclopramide and diphenhydramine (the MAD regimen) resulted in more patients with full headache relief after 24 hours than treatment with codeine in an outpatient obstetric unit (65.2 versus 28.6 percent).
“More patients also received headache relief with just one dose of the study medication (100 versus 61.9 percent), and more patients in the MAD group stated that they would use the medication again for a headache (95.7 versus 37.1 percent),” Childress said.
The investigators also found that patients reported shorter times to headache relief (15 versus 30 minutes) and spent less time in the triage unit (231 versus 242 minutes), although these differences were not statistically significant.
“The conclusion of the study is that a regimen of intravenous metoclopramide and diphenhydramine is effective at treating headache symptoms in obstetric patients in an outpatient setting when acetaminophen had failed. It is cost-effective, with only a small increase in cost from codeine,” Childress said.
Nayo Shepard Williams, M.D., of the Rutgers Robert Wood Johnson Medical School in New Brunswick, N.J., and colleagues compared the time of onset of symptomatic relief from vaginal yeast infections in women who received a local vaginal antifungal preparation and women who received a systemic oral antifungal agent. The investigators found that treatment with a local vaginal antifungal preparation was associated with faster symptom relief compared to systemic antifungal treatment.
“The local vaginal antifungal preparation system provided faster median times for initial relief of the vulvovaginal candidiasis symptoms of itching, burning, and irritation individually and for all symptoms combined than the systemic oral antifungal approach,” the authors write.
ACOG: More Women Opting for Unsupervised Home Births
MONDAY, May 4, 2015 (HealthDay News) — Home births without a midwife or doctor present — which have been linked to increased risk of infant death and disease — have jumped 79 percent in the United States in recent years, researchers report. The findings are scheduled for presentation at the annual meeting of the American College of Obstetricians and Gynecologists, held from May 2 to 6 in San Francisco.
ACOG: Pregnant Women May Believe E-Cigarettes OK
FRIDAY, May 1, 2015 (HealthDay News) — More than 40 percent of pregnant women surveyed think electronic cigarettes are less harmful than tobacco cigarettes, according to a new study. The results of the study are scheduled to be presented at the annual meeting of the American College of Obstetricians and Gynecologists, held from May 2 to 6 in San Francisco.
Copyright © 2015 HealthDay. All rights reserved.